MyFinsight
Home
Blog
About
Contact
Proceeds from exercise of
common stock options
$101K
Net cash provided by
financing activities
$101K
Net change in cash
for period
-$15,379K
Canceled cashflow
$101K
Depreciation and
amortization
$1,132K
Stock-based compensation
expense
$726K
Other current assets
and liabilities
-$187K
Other
-$120K
Amortization of debt
discounts
$50K
Sales of marketable
securities
$17,783K
Net cash used in
operating activities
-$12,358K
Net cash used in
investing activities
-$3,122K
Canceled cashflow
$2,215K
Canceled cashflow
$17,783K
Gross profit
$12,986K
Total other (income)
expense
$597K
Net loss
-$8,379K
Accounts payable
-$3,219K
Trade accounts
receivable
$2,389K
Purchases of marketable
securities
$18,170K
Canceled cashflow
$13,583K
Inventory
$238K
Prepaid expenses
$187K
Realized gain on
marketable securities
$161K
Fixed asset purchases
$2,735K
General and
administrative
$8,625K
Sales and marketing
$8,276K
Research and development
$3,754K
Medical education
$1,307K
Back
Back
Cash Flow
SHOULDER INNOVATIONS, INC. (SI)
SHOULDER INNOVATIONS, INC. (SI)
source: myfinsight.com